Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Neurology | Family Medicine | Orthopedics/Orthopedic Surgery
Disease Category: Lower Back Pain
Location: United States, UT

Clinical Trial Details

Overview

Research Study Summary

Lumbosacral radicular Pain associated with disk herniation (low back pain;/sciatica)

Purpose

A Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study to evaluate the Safety and Efficacy of CEP-37247 Administered at Single Doses of 0.5,1,3,6 or 12 mg by the Transforaminal Epidural Route for the treatment of Patients With Lumbosacral Radicular Pain Associated with Disk Herniation.

Patient Inclusion Criteria:

  • Male or Female ages 18 through 70 years of age
  • Current diagnosis of Lumbosacral Radicular pain between 6 and 52 weeks duration

Patient Exclusion Criteria:

  • BMI greater than 35 kg/m2
  • patient has received an intra-epidural steroid injection during last 3 months
  • Radicular pain at more than 1 spinal nerve
  • Corticosteroid injections in the back within 6 months of screening

To Learn more
Phase

1/2

Gender

Both Male and Female

Age

18 to 70 Years

Overall Status

Recruiting

Facility Type

N/A

Contact

Cher Struck, Director Marketing and Recruiting
Lifetree Clinical Research
3838 South 700 East Suite 202
Salt Lake City, UT 84106
Phone: 801-269-8200

View Map

Research Center Information: Lifetree Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 180842

Date Last Changed: July 19, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.